|
|
||||||||
The FASEB Journal, Vol 9, 73-80, Copyright © 1995 by The Federation of American Societies for Experimental Biology
REVIEWS |
R Raag and M Whitlow
Department of Chemistry, University of California at Berkeley 94720.
Single-chain Fvs (sFvs) are recombinant antibody fragments consisting of only the variable light chain (VL) and variable heavy chain (VH) domains covalently connected to one another by a polypeptide linker. Due to their small size, sFvs have rapid pharmacokinetics and tumor penetration in vivo. Single-chain Fvs also show a concentration- dependent tendency to oligomerize. Bivalent sFvs are formed when the variable domains of a sFv disassociate from one another and reassociate with the variable domains of a second sFv. Similar rearrangement and reassociation of variable domains from different sFvs can result in the formation of trimers or higher multimeric oligomers. Each Fv in a bivalent or multivalent Fv is composed of the VL domain from one sFv and the VH domain from a second sFv. Modifying linker length or the inclusion of antigen may stabilize the VL/VH interface against rearrangement such that specific multimeric or monomeric forms of sFvs may be isolated. Nuclear magnetic resonance studies have shown that McPC603-derived Fv and sFvs have similar structures, and that the sFv linker is a rapidly moving, highly flexible peptide with a random coil- like structure. In X-ray crystallographic investigations of three different sFvs, linkers have also been found to be disordered. Indirect evidence suggests that a monomeric sFv has been crystallized in one case, and dimeric sFvs in the other two.
This article has been cited by other articles:
![]() |
T. J. LaRocca, L. I. Katona, D. G. Thanassi, and J. L. Benach Bactericidal Action of a Complement-Independent Antibody against Relapsing Fever Borrelia Resides in Its Variable Region J. Immunol., May 1, 2008; 180(9): 6222 - 6228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghosh, R. Seward, C. E. Costello, B. D. Stollar, and B. T. Huber Autoantibodies from Synovial Lesions in Chronic, Antibiotic Treatment-Resistant Lyme Arthritis Bind Cytokeratin-10 J. Immunol., August 15, 2006; 177(4): 2486 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Donofrio, F. L. Heppner, M. Polymenidou, C. Musahl, and A. Aguzzi Paracrine Inhibition of Prion Propagation by Anti-PrP Single-Chain Fv Miniantibodies J. Virol., July 1, 2005; 79(13): 8330 - 8338. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Monedero, J. Rodriguez-Diaz, R. Viana, J. Buesa, and G. Perez-Martinez Selection of Single-Chain Antibodies against the VP8* Subunit of Rotavirus VP4 Outer Capsid Protein and Their Expression in Lactobacillus casei Appl. Envir. Microbiol., November 1, 2004; 70(11): 6936 - 6939. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Mooney and R. Landick Tethering {sigma}70 to RNA polymerase reveals high in vivo activity of {sigma} factors and {sigma}70-dependent pausing at promoter-distal locations Genes & Dev., November 15, 2003; 17(22): 2839 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gao, S. Mao, G. Kaufmann, P. Wirsching, R. A. Lerner, and K. D. Janda A method for the generation of combinatorial antibody libraries using pIX phage display PNAS, October 1, 2002; 99(20): 12612 - 12616. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Tazzari, L. Polito, A. Bolognesi, M.-P. Pistillo, P. Capanni, G. L. Palmisano, R. M. Lemoli, A. Curti, L. Biancone, G. Camussi, et al. Immunotoxins Containing Recombinant Anti-CTLA-4 Single-Chain Fragment Variable Antibodies and Saporin: In Vitro Results and In Vivo Effects in an Acute Rejection Model J. Immunol., October 15, 2001; 167(8): 4222 - 4229. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kuhlman, J. W. O'Neill, D. E. Kim, K. Y. J. Zhang, and D. Baker Conversion of monomeric protein L to an obligate dimer by computational protein design PNAS, August 23, 2001; (2001) 181354398. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rousseau, J. W. H. Schymkowitz, H. R. Wilkinson, and L. S. Itzhaki Three-dimensional domain swapping in p13suc1 occurs in the unfolded state and is controlled by conserved proline residues PNAS, May 8, 2001; 98(10): 5596 - 5601. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Ogihara, G. Ghirlanda, J. W. Bryson, M. Gingery, W. F. DeGrado, and D. Eisenberg Design of three-dimensional domain-swapped dimers and fibrous oligomers PNAS, February 13, 2001; 98(4): 1404 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eriksson, M. Vehniainen, T. Jansen, V. Meretoja, P. Saviranta, K. Pettersson, and T. Lovgren Dual-Label Time-resolved Immunofluorometric Assay of Free and Total Prostate-specific Antigen Based on Recombinant Fab Fragments Clin. Chem., May 1, 2000; 46(5): 658 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Zavala, T. Lancaster, J. D. Groopman, P. T. Strickland, and S. Chandrasegaran Phage display of ScFv peptides recognizing the thymidine(6-4)thymidine photoproduct Nucleic Acids Res., April 1, 2000; 28(7): e24 - e24. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Kuan, C. J. Reist, C. F. Foulon, I. A. J. Lorimer, G. Archer, C. N. Pegram, I. Pastan, M. R. Zalutsky, and D. D. Bigner 125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts Clin. Cancer Res., June 1, 1999; 5(6): 1539 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shan, O. W. Press, T. T. Tsu, M. S. Hayden, and J. A. Ledbetter Characterization of scFv-Ig Constructs Generated from the Anti-CD20 mAb 1F5 Using Linker Peptides of Varying Lengths J. Immunol., June 1, 1999; 162(11): 6589 - 6595. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gao, S. Mao, C.-H. L. Lo, P. Wirsching, R. A. Lerner, and K. D. Janda Making artificial antibodies: A format for phage display of combinatorial heterodimeric arrays PNAS, May 25, 1999; 96(11): 6025 - 6030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bosilevac, C. A. Gilchrist, P. E. Jankowski, S. Paul, A. R. Rees, and S. H. Hinrichs Inhibition of Activating Transcription Factor 1- and cAMP-responsive Element-binding Protein-activated Transcription by an Intracellular Single Chain Fv Fragment J. Biol. Chem., July 3, 1998; 273(27): 16874 - 16879. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sano, S. Vajda, C. L. Smith, and C. R. Cantor Engineering subunit association of multisubunit proteins: A dimeric streptavidin PNAS, June 10, 1997; 94(12): 6153 - 6158. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Mallender, J. Carrero, and E. W. Voss Jr. Comparative Properties of the Single Chain Antibody and Fv Derivatives of mAb 4-4-20 J. Biol. Chem., March 8, 1996; 271(10): 5338 - 5346. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Cho, B. A. Schodin, and D. M. Kranz Characterization of a Single-chain Antibody to the beta-Chain of the T Cell Receptor J. Biol. Chem., October 27, 1995; 270(43): 25819 - 25826. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Ireton, L. Stewart, L. H. Parker, and J. J. Champoux Expression of Human Topoisomerase I with a Partial Deletion of the Linker Region Yields Monomeric and Dimeric Enzymes That Respond Differently to Camptothecin J. Biol. Chem., August 11, 2000; 275(33): 25820 - 25830. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kuhlman, J. W. O'Neill, D. E. Kim, K. Y. J. Zhang, and D. Baker Conversion of monomeric protein L to an obligate dimer by computational protein design PNAS, September 11, 2001; 98(19): 10687 - 10691. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |